TGFBR2 and systemic sclerosis: PBMCs obtained from patients with SSc-ILD as well as lung tissues obtained from bleomycin-induced SSc-ILD mouse models showed reduced levels of miR-320a, which negatively regulates the expression of collagen genes by directly binding to and inhibiting TGFBR2 and IGF1R (48).